Laxmi Dental DuPont analysis

·Pharma & HealthChart ›
ProfitabilityGrowthCreditLiquidityWorking capitalDividend yieldDuPontCAGR
Per cent unless marked ×
Tap a line for its trendLast 12Mto Jun 2026FY26Mar 2026FY25Mar 2025
5-step DuPont — ROE = tax burden × interest burden × EBIT margin × turnover × leverage
0.99×1.00×1.00×
1.07×1.05×1.19×
10.2%9.9%11.2%
0.96×0.96×0.84×
1.20×1.20×1.36×
12.4%12.0%15.3%
12.8%12.8%15.2%
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

LAXMIDENTL₹177.37

Laxmi Dental Limited

· Pharma & Health
₹ CrorePeersFABTECHTARSONSFISCHERGKBMcap ₹975 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
5-Step DuPont — ROE = Tax Burden × Interest Burden × EBIT Margin × Turnover × Leverage
Tax Burden (Net Income/Pretax) ×1.001.000.99
Interest Burden (Pretax/EBIT) ×1.191.051.07
EBIT Margin %11.239.9110.19
Asset Turnover ×0.840.960.96
Financial Leverage (Assets/Equity) ×1.361.201.20
ROE (5-step product, year-end total equity) %15.2512.0312.45
ROE (owners' profit / average owners' equity) %15.2412.8312.83
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.